SCHEMBL21286089

SCHEMBL21286089

C[C@H](CN)c1ccc(Cl)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.60
ADRB2 P07550 1/20 0.56
GABBR2 O75899 6/20 0.46
GABBR1 Q9UBS5 6/20 0.46
LMNA P02545 3/20 0.46
CYP2C9 P11712 2/20 0.46
CYP1A2 P05177 2/20 0.46
THRB P10828 2/20 0.46
CYP3A4 P08684 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
NFKB1 P19838 1/20 0.46
DRD3 P35462 1/20 0.46
BLM P54132 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
MEN1 O00255 1/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 1/20 0.46
SLC6A3 Q01959 2/20 0.45
SLC6A4 P31645 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21286098 1.00 TAAR1 (0.60) TAAR1ADRB2GABBR2GABBR1LMNA
SCHEMBL1032332 1.00 TAAR1 (0.60) TAAR1ADRB2GABBR2GABBR1LMNA
Hydrochloric Acid SCHEMBL1570094 0.98 TAAR1 (0.58) TAAR1ADRB2GABBR2GABBR1LMNA
SCHEMBL11493598 0.94 TAAR1 (0.54) TAAR1ADRB2GABBR2GABBR1LMNA
SCHEMBL11487785 0.88 TAAR1 (0.48) TAAR1ADRB2GABBR2GABBR1LMNA
SCHEMBL3006604 0.87 TAAR1 (0.75) TAAR1NFKB1TSHRAOC3
Hydrochloric Acid SCHEMBL6564727 0.85 TAAR1 (0.71) TAAR1NFKB1TSHRAOC3
Hydrochloric Acid SCHEMBL5877955 0.83 TAAR1 (0.62) TAAR1ADRB2SMN1; SMN2
SCHEMBL6222745 0.82 ADRB2 (0.52) TAAR1ADRB2GABBR2GABBR1LMNA
SCHEMBL11566936 0.79 ADRB2 (0.48) TAAR1ADRB2GABBR2GABBR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752497-B1 P300/CBP HAT INHIBITORS CONSTELLATION PHARMACEUTICALS INC (US) 2024-07-17 EP disclosed
WO-2021021893-A1 COMPOUNDS FOR USE IN TREATING NEUROLOGICAL DISORDERS CONSTELLATION PHARMACEUTICALS, INC. (US) 2021-02-04 WO disclosed
WO-2019161162-A1 P300/CBP HAT INHIBITORS CONSTELLATION PHARMACEUTICALS, INC. (US) 2019-08-22 WO disclosed